Stravynski A, Verreault R, Gaudette G, Langlois R, Gagnier S, Larose M
Department of Psychiatry, University of Montreal.
Can J Psychiatry. 1994 Sep;39(7):387-90. doi: 10.1177/070674379403900701.
Twenty-four outpatients meeting DSM-III-R criteria for major depression were assigned to group behavioral-cognitive therapy either with or without antidepressant medication (imipramine). Eighteen patients completed 15 weekly sessions of treatment. Equivalent improvement was observed in both regimens after treatment. The results essentially maintained at six months follow-up. This suggests that a group format of behavioural-cognitive therapy is a viable therapeutic intervention for outpatients diagnosed as suffering from major depression. However, the addition of imipramine to group behavioural-cognitive therapy did not enhance the outcome.
24名符合《精神疾病诊断与统计手册》第三版修订本（DSM-III-R）中重度抑郁症标准的门诊患者被分配接受有或无抗抑郁药物（丙咪嗪）的团体行为认知疗法。18名患者完成了为期15周的治疗课程。治疗后，两种治疗方案均观察到同等程度的改善。结果在六个月的随访中基本保持稳定。这表明团体行为认知疗法对于被诊断患有重度抑郁症的门诊患者是一种可行的治疗干预方法。然而，在团体行为认知疗法中添加丙咪嗪并没有提高治疗效果。
